Human connections for better collaborations: Highlights from the 2026 Annual Meeting of the Africa Pandemic Sciences Collaborative

How many things can change in just over a year? 

When the Africa Pandemic Sciences Collaborative members convened for the first time last year, we shared a common vision of advancing pandemic sciences across the continent. Our EPSILONs, the seven consortia of research excellence we are supporting, had just been formed; we had ideas and plans, but several of the people now sharing our journey weren’t even with us yet.  

At our second Annual Meeting, hosted in August in Oxford, we fully realised how much the Collaborative has grown in the meantime, both in size and in ambition. From vaccinology and virology to clinical trials and surveillance, and from modelling to ethics and policy – the Collaborative’s research is already contributing to real-world epidemic preparedness and response, including to the Bundibugyo Ebolavirus outbreak.  

During the Annual Meeting, research updates were often shared by our early-career scientists, who spoke with confidence and authority in representation of a growing cohort of up-and-comingscientists and professionals. This is what the Collaborative aims to do – nurture the next generation of African scientists and enable them to strengthen pandemic resilience in Africa and worldwide.  

The Collaborative, however, is more than a network of researchers. It’s the technicians who support research activities; the finance professionals who help run projects smoothly, sustainably and compliantly; the programme teams who make sure that lasting change can be delivered. It’s the MEAL specialists who track impact and ensure accountability; the communications professionals who mobilise vital information; and the policy teams who help transform research into effective solutions.  

With these colleagues and many more – from our partner institutions, our EPSILONs and our broader network – we spent five days constantly learning from each other. Meetings like these consolidaterelationships and increase mutual trust, leading to better collaborations that are informed by different perspectives and expertise. 

We don’t simply want our researchers to succeed. We want our institutions to emerge more robust and resilient, helping create a solid ecosystem where one’s strength is everybody’s strength.  Where clear pipelines to policy and practice exist, allowing our work to improve the lives of our people. 

That’s how, together, we will nurture and equip an emerging generation of young African scientists to tackle epidemic and pandemic threats – today and in the future.

SHARPER Team Convened at the University of Cape Town, Attended the World Congress on Public Health, and Delivered Two Sessions that Promote Rights-Based and Population-Focused Health Research Benefit-Sharing

Annual Cross-Site Meeting: Reflecting, Strategising, and Strengthening Collaboration

From 10th to 12th September 2026, the SHARPER Project team convened at the University of Cape Town for its annual cross-site meeting, bringing together ten researchers and partners from across participating institutions to review progress, reflect on achievements, and strategically plan priorities for the year ahead.

The meeting provided an important platform for partners to assess ongoing activities across project sites, share experiences, discuss emerging challenges, and strengthen collaboration towards achieving SHARPER’s objectives of advancing ethical, rights-based, and population-focused approaches to health research.

Through constructive discussions and strategic planning sessions, the team reviewed implementation progress, identified opportunities for strengthening cross-site learning, and aligned future activities to ensure continued impact across research, policy, and practice. The meeting reinforced the value of collaborative approaches in addressing complex public health challenges and promoting research systems that prioritise ethics, equity, and meaningful benefits for populations.

Before the meeting, the SHARPER team participated in the World Congress on Public Health held between September 6-9, 2026, at the Cape Town International Convention Center, where the team contributed to global conversations on strengthening ethical and equitable approaches to health research.

Interactive Workshop and Role-Play, titled: If We Really Want Pandemic Preparedness, We Must Ensure Equity and Justice – The Role of Ethics Committees and Researchers in Promoting Population Benefits from Health Research

On 6th September 2026, at the 2026 World Congress on Public Health held in Cape Town, SHARPER Project organised an interactive workshop exploring the responsibilities of researchers, ethics committees, and health research stakeholders in ensuring that research generates meaningful benefits for populations.

The workshop brought together the expertise and leadership of SHARPER investigators and partners from different African institutions and public health networks, including representatives from the University of Cape Town, South Africa; University of Ibadan, Nigeria; Cameroon Bioethics Initiative, Cameroon; Tropical Institute for Community Health, Kenya; Kamuzu University, Malawi; and Afya na Haki, Uganda.

A central feature of the workshop was a mock Research Ethics Committee (REC) meeting through role-play involving the ethical review of a proposed artificial intelligence (AI)-guided diagnostic study for cardiomyopathy. The role-play simulated an ethics committee review process, allowing participants to identify practical ethical challenges related to AI-driven health research, conflicts of interest, technology ownership, and equitable access to research benefits.

The role-play involved a simulated REC meeting consisting of a chair, a committee member presenting the research protocol, an additional committee member raising ethical concerns, and audience volunteers participating as REC members. Through this approach, participants were encouraged to critically examine how ethics committees assess not only scientific validity and participant protection but also broader questions of justice and benefit sharing.

During the discussion, participants explored whether researchers and sponsors have responsibilities beyond conducting scientifically valid studies, particularly regarding access to successful interventions after research completion. The session examined the importance of developing proactive plans to ensure that communities contributing to research are not excluded from benefiting from resulting innovations.

Following the role-play, participants reflected on the ethical issues raised through an interactive audience engagement exercise using Mentimeter. Discussions focused on questions including whether participants were treated fairly, whether the research adequately addressed population benefits, and whether the protocol sufficiently considered equitable benefit sharing.

The lessons from the workshop reinforced the importance of integrating equity, justice, and accountability into health research governance. Participants reflected on how ethics committees can play a stronger role in ensuring that research conducted in African contexts contributes to sustainable health improvements and meaningful benefits for African populations.

Poster Presentation: Why Ethics, Human Rights, and Population Benefits Matter

Following the workshop, the SHARPER Project presented a poster exploring the critical importance of ethics, human rights, and population benefits in shaping responsible health research.

The presentation highlighted the need to move beyond traditional approaches to research ethics that primarily focus on protecting individual participants, towards broader considerations of justice, equity, accountability, and the fair distribution of benefits arising from research. The presentation emphasised that public health research should not only generate scientific knowledge but also contribute meaningfully to improving the wellbeing of populations, particularly communities that participate in research and contribute to the advancement of health innovations.

Drawing on SHARPER’s mission to strengthen healthcare and apply research for population health, ethics, and rights, the poster presentation stimulated discussions around how researchers, ethics committees, policymakers, and communities can work together to ensure that research outcomes translate into sustainable population benefits. It also provided an opportunity to engage conference participants on the role of ethical frameworks in addressing global health inequalities and ensuring that advances in health research are accessible, equitable, and socially responsive.

Ultimately, SHARPER Project’s activities at the World Congress on Public Health highlighted three important messages. Firstly, ethical health research must consider not only how research is conducted, but also who benefits from its outcomes. Secondly, human rights and equity must remain central to decisions about research design, governance, and implementation. Lastly, researchers, ethics committees, governments, regulating agencies and communities share responsibility for ensuring that health innovations translate into population benefits.

Through the interactive workshop and poster presentation, SHARPER created opportunities for critical reflection and dialogue on strengthening ethical research systems and ensuring that public health research better serves populations.

Cocktail at the University of Cape Town Leadership

At the conclusion of the annual meeting and World Congress activities, on 12th September 2026, the SHARPER Project team held a cocktail with the Deputy Vice-Chancellor of the University of Cape Town, and some UCT management staff at the All Africa House. The meeting provided an opportunity for the team to formally acknowledge the support and institutional environment that enabled the successful convening of SHARPER activities in UCT. Discussions during the cocktail visit reaffirmed the importance of strengthening partnerships, advancing collaborative research, and continuing efforts to promote ethical, equitable, and impactful approaches to public health research.

SHARPER Project is being implemented with the support of the Africa Pandemic Sciences Collaborative, a multi-year partnership between the Science for Africa Foundation, the Pandemic Sciences Institute at the University of Oxford, and the Mastercard Foundation.

Follow the SHARPER Project social media channels for updates on engagements focused on ensuring that health research delivers meaningful benefits for populations.

Written by Adams Adeshola, Communications Officer, SHARPER Project. 

From Kibong’oto Infectious Diseases Hospital to Tanzania Infectious Diseases Institute: A milestone for infectious disease preparedness in Tanzania and the continent

A century after its establishment as a tuberculosis (TB) sanatorium, Kibong’oto Infectious Diseases Hospital (KIDH) has reached a defining milestone in its history. After more than a decade of sustained investment in scientific expertise, research infrastructure, and institutional systems, KIDH has been elevated into the Tanzania Infectious Diseases Institute (TIDI), a significant step forward for Tanzania’s infectious disease preparedness.

On 24 July 2026, through a Government Gazette Notice No. 216 of 2026, the Government of Tanzania formally established TIDI. The new institute expands KIDH’s mandate beyond specialized clinical care to include a broader national role in infectious disease research, preparedness, rapid response, and scientific capacity development.

This significant milestone coincides with 100 years of TB services at Kibong’oto. From its origins as a TB sanatorium in 1926, the institution has evolved into a national institute positioned to address a wider range of infectious disease threats.

“The transition to TIDI represents the most significant transformation in Kibong’oto’s 100-year history. It broadens our role from specialised infectious-disease care to a national platform for research, surveillance, preparedness, training and innovation, while strengthening Tanzania’s contribution to regional and global health security.”

— Professor Stellah Mpagama, Director of Research Training and Innovations Tanzania Infectious Diseases Institute (TIDI)

Prof Stellah Mpagama at Tanzania Infectious Diseases Institute (TIDI)

This transformation reflects the changing health landscape in Tanzania and the wider East African region, where emerging and re-emerging infectious diseases continue to pose a growing risk. The establishment of TIDI represents an important step towards strengthening Tanzania’s ability to anticipate, investigate, and respond to future health threats. Strengthening national instituitions that can connect specialized clinical care with research, evidence generation, clinical trials and rapid response is increasingly important.

The transformation did not happen overnight

For more than a decade, KIDH has received sustained investment towards strengthening its technical, research, and administrative capacity. During this period, the institution developed specialized expertise in managing drug-resistant TB and other infectious diseases, expanded its outreach to underserved and marginalized communities, and strengthened its laboratory and research infrastructure.

The Kibong’oto Public Health Laboratory

KIDH also established the capacity to conduct Phase II and III clinical trials in TB and HIV, demonstrating its growing role as a centre for high-quality clinical research. These investments provided a strong foundation for the institution’s expanded mandate.

Intensive Care Unit Building

More recently, participation in the Advancing Capacity for Early Phase Trials for Pandemics and Epidemics in Africa (ACCEPT-Africa) consortium has supported the next stage of this journey. Through the consortium, KIDH/TIDI is strengthening its readiness to conduct early-phase clinical trials, including the development of Phase I capabilities, stronger clinical and research systems, and multidisciplinary research teams.

Collaboration with the Infectious Diseases Institute (IDI) at Makerere University, and other consortium partners has also created opportunities for technical learning, knowledge exchange, and regional collaboration. These partnerships are helping strengthen the capacity of African institutions to prepare for and respond to future epidemics and pandemics.

Additionally, investment in people has been central to KIDH’s transformation. The institution has supported the development of a growing generation of researchers and research leaders, including more than 25 MSc trainees, 19 PhD trainees, and 15 postdoctoral trainees. It has also developed seven research administration personnel and strengthened grant management and institutional governance.

“I was a PhD fellow in the ReMODEL training programme at TIDI, formerly KIDH, which was supported by EDCTP2. Through this programme, I networked and worked with several other consortia, including the Training Health Researchers in Vocational Excellence (ThRIVE-2) and the Application of Genomics and Modelling to the Control of Virus Pathogens in East Africa (GeMVi), the latter supported by NIHR. The programme strengthened my early-career research skills, including conceptual, technical and interpersonal skills in pathogen genomics, which have created a spillover effect into the ACCEPT-Africa consortium.”

— Dr. Shabani Mziray, Laboratory Scientist

Together, these investments have strengthened the expertise and systems needed to manage complex research programmes, attract competitive funding, and generate evidence that responds to Tanzania’s health priorities.

The impact of TIDI extends beyond the institution itself

For Tanzanian researchers and young scientists, the revised institutional mandate creates new opportunities to build careers in advanced infectious disease research while contributing to solutions for health challenges facing their own communities.

For patients and communities, the institute offers the potential for greater access to specialized expertise and research-informed care. It also provides a stronger platform for evidence generated in Tanzania to inform responses to the health threats affecting Tanzanian communities.

The transformation into the Tanzania Infectious Diseases Institute (TIDI) is more than a change of name. From its beginnings as a TB sanatorium in 1926 to a national infectious diseases institute a century later, TIDI’s journey demonstrates what sustained investment in people, infrastructure, institutions and partnerships can achieve over time. For the ACCEPT-Africa consortium, this milestone provides a tangible example of how investments in clinical trial readiness and scientific capacity can contribute to lasting institutional development, while creating opportunities to strengthen Tanzania’s research ecosystem and its contribution to regional pandemic preparedness.

As TIDI begins this new chapter, it is better positioned to advance clinical and infectious disease research, generate evidence, develop scientific leaders and strengthen Tanzania’s capacity to respond to emerging health threats. The next phase will focus on translating this expanded mandate into stronger research infrastructure, early-phase clinical research capability and new opportunities for collaboration. Together, TIDI and ACCEPT-Africa can help build a stronger platform for pandemic research in Tanzania and across Africa, bringing researchers, institutions, policymakers and partners together to share expertise, deepen collaboration and contribute to a more resilient continental research ecosystem.

Tanzania Infectious Diseases Institute’s (TIDI) Radiology building

Written by Onai Yambazi, Communications Officer, ACCEPT-Africa consortium

Three Consortia, One Mandate: Inside Uganda’s EPSILONs Unified Pandemic Preparedness and Response System

The lull between outbreaks is often defined by a quiet, dangerous erosion: trained personnel move on, specialized laboratories pivot, and institutional memory fades. When the next virus occurs, Africa’s scientific community is forced to rebuild its response efforts from scratch.

On July 31, 2026, inside the Sande McKinnell Centre at Makerere University’s Infectious Diseases Institute (IDI) three Ugandan-based Epidemic and Pandemic Sciences Innovation and Leadership Networks (EPSILONs) consortia committed to a different approach: build connections before the next outbreak, not during it.

The Uganda EPSILON Mini-Launch brought together: Advancing Capacity for Early Phase Trials for Pandemics and Epidemics in Africa (ACCEPT-Africa), Prevention and Response to Emerging viruses with Pandemic potential in Africa Epsilon (PREPARE) and Strengthening Health systems capacity in Africa for Pandemic Equity and Responsiveness (SHARPER) – three consortia working across different but interconnected areas of pandemic preparedness under the Africa Pandemic Sciences Collaborative. Their meeting marked a shift from parallel efforts towards greater collaboration and long-term capacity building.

Beyond Parallel Silos

Each consortium brings a distinct capability to Uganda’s pandemic preparedness.

ACCEPT-Africa focuses on clinical trials and medical countermeasures, building the capacity to design and conduct early-phase clinical trials in Africa. PREPARE is focused on an early vaccine and diagnostic development for priority pathogens

 helping generate timely evidence on emerging pathogens. SHARPER focuses on the social, ethical and community dimensions that underpin effective research and response.

“ACCEPT-Africa was built to move fast when speed matters most,” said Dr Christine Sekaggya-Wiltshire, who leads the consortia. “But no single network can prepare a country alone. Standing alongside SHARPER and PREPARE today means we can pool our strengths, share what each of us has learned, and respond as one system instead of three.”

 “Preparedness cannot live in silos,” added Dr Andrew Kambugu, IDI’s Executive Director. “Today’s Mini-Launch is IDI’s commitment to a Uganda where our pandemic science networks plan together, train together, and respond together, long before the next outbreak begins.”

The gathering brought together representatives from Uganda’s Ministry of Health, Makerere University College of Health Sciences, Africa CDC, the Science for Africa Foundation and research institutions, reflecting the range of actors needed to translate scientific capacity into effective preparedness.

The Case for Each Other

The morning’s presentations showed why the three consortia need each other.

Dr Daniel Kiiza laid out ACCEPT-Africa’s ambition to build a sustainable pool of independent African research scientists capable of designing and running early-phase trials rather than Africa remaining a site where products developed elsewhere are simply tested.

Dr Joyce Namulondo described PREPARE’s push to close the gap between an outbreak starting and a pathogen being understood. Using influenza as an example, she highlighted the role of genomic surveillance in tracking rapidly evolving viruses and generating evidence that can inform vaccine development.

Nimrod Muhumuza presented SHARPER’s case that no amount of laboratory excellence survives contact with a community that does not trust the response. The consortium’s guiding line was that researchers must not simply take science to communities but build science with them.

Together, the presentations made a simple point: detecting a pathogen, developing a medical response, and ensuring that communities can participate in and benefit from that response are not separate challenges. They are parts of the same pandemic preparedness and response system.

Building Science with the Community

The afternoon’s panel discussions moved quickly past administrative goals to address the stark realities of field deployment. When asked how response teams can navigate mistrust such as the tragic attacks on Ebola treatment units seen in neighbouring DRC during the 2026 outbreak, the consensus was unequivocal: technical excellence fails if community trust is absent.

Dr Moses Mulumba spoke about SHARPER’s focus on an “Afrocentric” approach to research, including examining whether research standards developed elsewhere adequately reflect African contexts and values. The approach also asks a broader question: whether communities are merely sources of data or participants who should experience meaningful benefits from the research.

Dr Christine Sekaggya-Wiltshire put it plainly: “We go beyond just the clinical trials; we build synergies with communities to understand their perceptions towards the work we are doing.”

Empowering Tomorrow’s Science Leaders

Central to the Africa Pandemic Sciences Collaborative’s mandate is ensuring that early-career researchers do not remain in administrative shadows. To operationalize this, Dr Sekaggya described ACCEPT-Africa’s Catalyst Groups in pharmacokinetics, clinical trials, bio-ethics and behavioral science, where junior scientists apply for grants under senior mentorship rather than waiting years to lead their first study.

Dr. Linda Murungi, Program Manager for the Africa Pandemic Sciences Collaborative, widened the definition of capacity building further. “It is not only about scientists,” she reminded the room, “but also the finance officers, grants managers and policy specialists who make African-led research possible. This institutional infrastructure may be less visible, but without it, no scientific breakthrough can survive.”

As the mini-launch concluded in Kampala, the significance of bringing the three consortia together was becoming clearer. Uganda’s pandemic preparedness does not depend on any single laboratory, research network or discipline. It depends on whether those capabilities can connect when they are needed.

When she spoke, people listened: Meet Vimbai Mukwekwezeke, One of the Newest Member of the Policy Advisory Stakeholders Group (PAS-G)

Some people spend years searching for their voice.

Vimbai realised she had already found hers.

Whenever she spoke, people listened.

It was something she began to notice in meetings with colleagues, during technical discussions, and later, in the policy conversations that emerged throughout the COVID-19 pandemic. Her ideas resonated. Her arguments carried weight. Increasingly, she found herself helping bridge the gap between research and the decisions that shape public health.

What began as a quiet observation soon became a calling.

“When I’m talking about policy,” she says, “it’s something that I don’t have to think about. It just comes and starts making sense.”

Recently, Vimbai joined the Africa Pandemic Sciences Collaborative’s Policy Advisory Stakeholders Group (PAS-G) as one of its newest and youngest members, bringing expertise in research governance, infectious disease modelling, and evidence-informed policymaking. More importantly, she brings a conviction that good science only changes lives when the right people are prepared to listen.

Finding Her Path

Vimbai’s journey into policy was anything but conventional.

“My first degree was in Computer Information Systems,” she explains. “Then I moved into monitoring and evaluation, information systems management, bioethics, and infectious disease modelling. I borrowed from a lot of different disciplines to get where I am.”

Rather than following a single career path, she built one across disciplines, combining technical knowledge with an increasing appreciation for how research influences public policy.

Today, she serves as a Research Information and Compliance Officer at the Medical Research Council of Zimbabwe, working at the intersection of research governance, evidence generation and policy translation.

When Research Found Its Voice

The COVID-19 pandemic became a defining moment in Vimbai’s career.

As Zimbabwe responded to the crisis, researchers began connecting through virtual discussions that would eventually evolve into the Zimbabwe Infectious Diseases Modelling Consortium, a nationally recognised platform providing evidence and technical guidance to government.

Vimbai was part of that journey from the beginning.

“Some of our leaders became special advisers to the President, and we would feed them with information that was passed on to the Minister,” she recalls.

For the first time, she witnessed scientific evidence moving beyond research papers and into the rooms where national decisions were being made.

That experience transformed the way she viewed policy.

“When research comes in and we get dissemination results and study reports, some of those outcomes are translated into policy,” she says. “That’s how I became involved in this work.”

Today, she sees policy not as a collection of documents or procedures, but as the mechanism through which research creates real-world impact.

Making Evidence Matter

For Vimbai, good policy begins with good science.

“Good research results,” she says without hesitation, “means that the groundwork has been done well and  whatever is translated into policy has been thoroughly examined.”

But rigorous evidence alone does not guarantee change.

“We live in a diversified and highly political world,” she says. “We need to push harder for policies to be adopted.”

Her work has taught her that scientific evidence must compete for attention in complex political environments. Generating knowledge is only part of the challenge. Ensuring that knowledge informs decision-making is equally important.

Making Space at the Table

As a young African woman working at the science-policy interface, Vimbai understands what it means to fight for your voice to be heard.

“Women are not yet enough in these spaces,” she says.

She believes greater representation is essential – not simply because women deserve a seat at the table, but because better policymaking depends on diverse perspectives.

“I wish to be in government one day, perhaps in a ministerial position or as a permanent secretary,” she says. “If you look around right now, how many women are in policymaking roles? Very few. The space is not as welcoming as it should be.”

She points to the barriers that continue to limit women’s participation in policymaking across the continent.

“The doors are not open enough for us. You want to be heard, but often the doors are closed.”

Yet she also believes the landscape is beginning to change.

“Women now have the zeal to participate,” she says. “Despite not being heard before, we now have the confidence to say: ‘You have to hear us. Involve us.'”

One of the contributions she hopes to make through the Policy Advisory Stakeholders Group is helping amplify the voices of young researchers and creating more opportunities for women to participate in policy conversations.

“When you can talk in a small room with influential people, there is potential for your voice to be amplified into other bigger rooms,” she says. “It becomes a door. It becomes an opportunity.”

Vimbai with SIB Paul Marie Ange Auguste Anselme, the two newest members of the PAS-G

Beyond Zimbabwe

Joining the Collaborative’s Policy Advisory Stakeholders Group marks an important new chapter in Vimbai’s journey.

“The Collaborative’s Policy Advisory Stakeholder’s Group (PAS-G) has moved my work beyond the national level,” she says.

She hopes to contribute to a growing community of scientists and policymakers committed to strengthening evidence-informed decision-making across Africa while continuing to advocate for more efficient policy processes.

“If somebody comes up with a policy, it means a lot of work has already gone into it,” she says. “We live in a fast-moving world. It doesn’t make sense for highly qualified experts to bring forward a recommendation and then have it take an unnecessarily long time to move forward.”

Looking ahead, her ambition is clear: to help build systems where scientific evidence moves more quickly into action and where more young people and women help shape the decisions that affect millions of lives.

“What can stop me right now?” she reflects. “Nothing. I can see where I’m going. I can see what I really want to do.”

Years ago, Vimbai noticed something simple: whenever she spoke, people listened.

Today, she is using that voice for something much bigger than herself – helping ensure that when science speaks, policymakers listen too.

Fighting Malaria, Shaping Policy: Meet SIB Paul Marie Ange Auguste Anselme, One of the Newest Member of the Policy Advisory Stakeholders Group (PAS-G)

Every malaria statistic begins with a decision.

A decision about where limited resources should go. Which communities should receive vaccines first. Which interventions can save the greatest number of lives. And ultimately, which evidence policymakers choose to act upon.

For SIB Paul Marie Ange Auguste Anselme, these are not theoretical questions. They shape his work every day.

The scale of the challenge is staggering, with millions of malaria cases being recorded across Africa.Growing up and working in Burkina Faso, SIB has witnessed first-hand what happens when disease outpaces resources – and why good science alone is never enough. Unless evidence reaches policymakers, the people who need it most may never benefit from it.

It is this conviction that has shaped his career as a scientist and now brings him to the Africa Pandemic Sciences Collaborative’s Policy Advisory Stakeholders Group (PAS-G), where he joins a growing network of African researchers and policymakers working to strengthen the use of scientific evidence in decision-making across the continent.

From Research to Reality

A doctoral candidate in Medical Entomology at the Regional Institute of Health Sciences Research (IRSS/DRO) in Bobo-Dioulasso, SIB’s scientific journey spans biomedical analysis, bacteriology, virology and vector-borne disease research.

His institution’s work extends beyond malaria to include dengue fever, nutrition, sociology and infectious diseases, reflecting the interconnected nature of public health challenges. That multidisciplinary environment has shaped the way he approaches science – not as an end in itself, but as a tool for solving real-world problems.

For SIB, malaria remains one of the most urgent.

Despite decades of progress, Burkina Faso continues to carry an enormous malaria burden. In 2025 alone, the country recorded more than 10 million confirmed cases and approximately 3,500 deaths.

Behind those numbers, he sees children missing the chance to grow up healthy, families overwhelmed by illness, and a health system under constant pressure.

His team responded by strengthening prevention efforts, supporting the rollout of the new malaria vaccine and distributing long-lasting insecticidal nets (LLINs), particularly among the youngest and most vulnerable.

“The difficult choice was on who to prioritise; who bears the heaviest burden of disease?” He says, “We decided to focus heavily on prevention – new vaccine and long-lasting insecticidal nets – for the youngest children, because they are the ones most at risk of dying if nothing is done.”

When Evidence Meets Policy

Working on the frontlines of malaria control has taught SIB that scientific evidence does not automatically become public policy. Often, the greatest challenge lies in deciding where scarce resources should be invested.

“You know, it’s really difficult to do everything at once, given the enormous challenges and the scarcity of resources,” he explains. “We can’t do everything 100 per cent at the same time.”

Those realities have reinforced an important lesson for him: policymaking is rarely about choosing between good and bad options. More often, it is about making difficult decisions with limited resources while ensuring those decisions are informed by the best available evidence.

But evidence alone is rarely enough.

Implementing change also requires trust, dialogue, and an understanding of the people expected to embrace new approaches.

“Sometimes, to implement a major reform, especially in the healthcare sector, it’s necessary not only to adopt a pedagogical approach, but also to be willing to negotiate with stakeholders whose interests are often affected,” he says.

“These innovations very often encounter resistance from certain officials who are entrenched in outdated methods, and from a segment of the population that doesn’t always immediately grasp the proposed changes.”

For SIB, successful public health programmes depend as much on listening as they do on leading. His approach is simple: build trust first, communicate clearly, and turn resistance into collaboration.

Making Science Count

Throughout his career, SIB has remained focused on ensuring research does not stop at publication. His work is driven by a desire to see scientific findings translated into programmes, interventions and policies that improve people’s lives.

“Data plays a crucial role, especially in healthcare,” he says. “It is through this data that we gain credibility with policymakers and partners.”

Reaching communities is equally important. His team complements scientific research with public engagement through symposia, open-house events, and radio and television campaigns, recognising that meaningful public health action depends on both evidence and public understanding.

A Voice for the Next Generation

SIB joined the Policy Advisory Stakeholders Group.

As one of the youngest members of the Collaborative’s Policy Advisory Stakeholders Group, SIB brings his technical expertise in malaria research, as well as practical experience navigating the complex intersection of science, implementation and policymaking.

SIB Paul Marie Ange with Vimbai Mukwekwezeke, the two newest members of the PAS-G

But working with experienced policymakers in the PAS-G, he hopes to contribute his perspectives drawn from both research and field implementation while learning alongside fellow and seasoned scientists and policymakers committed to strengthening evidence-informed decision-making across Africa.

His ambition extends beyond malaria.

He wants to see more young African scientists equipped not only to generate evidence but also to understand how policy is shaped – and how scientific voices can influence the decisions that affect millions of people.

“It is through this that, together, our voices will carry more weight and credibility with our political leaders,” he says, “leading to a better Africa, safe from all pandemics.”

For SIB, the future of public health will not be determined by science alone.

It will be shaped by the choices leaders make with that science.

And every better decision begins with evidence.

SHARPER communication officer wins Best Oral Presentation Award at International Pandemic Conference 2026

Adams Adeshola, an early-career professional serving as the Communication Officer with the Strengthening Health Systems Capacity for Pandemic Equity and Responsiveness (SHARPER) project, won the Best Oral Presentation Award in the Ethics and Context category at the International Pandemic Sciences Conference in Singapore, held from 1–3 July 2026.

Adeshola’s presentation, titled Decolonising Research Ethics in Africa through Indigenous Language Institutionalisation: A Case Study of the Yoruba Language, was well received not only because of the relevance of the topic but also for his confident delivery. He argued that the informed consent process is often flawed, particularly when research involves complex medical terminology. He recommended that the use of indigenous African languages, such as Yoruba, which is widely spoken in south-west Nigeria, can improve participants’ understanding of research, foster trust between researchers and communities, and strengthen public engagement during disease outbreaks and pandemics. His presentation challenged conventional approaches to research ethics by demonstrating that effective communication is not merely a supporting component of public health but a critical pillar of ethical research, community participation, and pandemic preparedness.

Adeshola’s journey to the international stage began in January 2026 when the Pandemic Sciences Institute issued a call for abstracts for its annual conference. He submitted an abstract that was selected for oral presentation, and a bursary provided by the organisers enabled him to participate in the global event.

A graduate of the University of Ibadan, Adeshola holds a master’s degree in Linguistics and Languages. As SHARPER’s Communication Officer, he attended the conference to reinforce the project’s commitment to promoting ethical and community-centred research in Africa. His recognition marks a significant milestone for interdisciplinary scholarship, highlighting the growing importance of communication and the humanities in shaping research ethics and strengthening pandemic preparedness.

The three-day conference attracted leading researchers, policymakers, public health professionals and innovators from around the world to discuss some of the most pressing issues in pandemic sciences. Discussions covered a wide range of thematic areas, including Ethics and Context, Data, Analytics and Artificial Intelligence, Vaccines and Immunology, Diagnostics and Treatment, Pathogen Biology and Emerging Threats, and Policy and Governance.

Reflecting on receiving the award, Adeshola said:

“As the award presentation session was about to begin, I had taken out my phone simply to record the moment for those who would be recognised. So, when I heard my name called, I was overwhelmed with gratitude. To me, this award means far more than recognition for a presentation. It reaffirms my belief that ‘your background should never limit your future.’

As someone from the humanities, I know many young Africans believe that global health is reserved for those in the biomedical sciences. This experience, however, proves otherwise. Receiving recognition on a global stage affirms that communication, language, and other fields are not peripheral to global health; they are essential to building trust, strengthening research ethics, and improving pandemic preparedness. This award gives me even more confidence in the path I have chosen and inspires me to continue producing research that connects science with society. Above all, I hope it inspires other young people, especially those in the humanities, to believe that their voices matter and that they, too, belong on the global stage.”

Written by Prof Ademola Ajuwon, Principal Investigator of the SHARPER Consortium

SHARPER Project Features in Capacity Building Training for Early-Career Researchers at the University of Ibadan, Nigeria

The Strengthening Health Systems Capacity in Africa for Pandemic Equity and Responsiveness (SHARPER) Project featured in a capacity strengthening programme at the University of Ibadan (UI) for approximately 400 newly recruited lecturers. Organized by the Research Management Office (RMO) of the university, the programme was designed to support the professional development and integration of the Early-Career Researchers (ECR) into the university system. It is also a part of efforts to strengthen the institution’s human resource capacity and reinforce its commitment to fulfilling its vision to be a world class institution for academic excellence geared towards meeting societal needs.

To foster effective facilitator-participant interaction, the workshop was delivered to participants in two batches. While the first batch of participants were trained from 4th to 6th May, the second was held between 1st and 3rd June 2026. During these programmes, several key aspects of academic life and institutional practice were covered. The sessions focused on the social responsibilities of academics, the opportunities and challenges associated with scholarship, promotion guidelines, work-life balance, mentorship and career advancement strategies.

At the training, Prof. Ademola Ajuwon, the  Principal Investigator of the SHARPER Project, delivered an insightful lecture on grant writing and research strategies. He provided participants with practical tips on how to search and win grants, developing competitive proposals, and maintaining ethical and professional standards in research.

Speaking on the importance of research grants in academic career development, Prof. Ajuwon introduced participants to the SHARPER Project and the opportunities it offers for ECR.  He explained that the project is a six-year socio-behavioural science research initiative focused on strengthening health systems capacity, pandemic preparedness and responsiveness, research benefit-sharing, and the promotion of African values in research ethics.

He highlighted that the SHARPER Project would provide three categories of research support annually across its six partner institutions, namely the College of Medicine, University of Ibadan, Nigeria; University of Cape Town, South Africa; Tropical Institute of Community Health, Kenya; Afya na Haki, Uganda; Kamuzu University of Health Sciences, Malawi; and the Cameroon Bioethics Initiative, Cameroon. The University of Ibadan serves as the lead institution for the project.

According to Prof. Ajuwon, the project’s Research Innovation Grants will offer up to $40,000, while the Catalyst Awards will provide up to $15,000 in funding. In addition, the Exchange Fellowships valued at up to $10,000 will be available to support collaborative learning and research exposure across partner institutions. He encouraged the participants to monitor the project’s social media platforms, particularly Facebook and LinkedIn, for upcoming Calls for Applications (CFAs). He also emphasised the project’s commitment to promoting inclusivity and equity in research participation, noting that women and applicants under 35 would receive priority consideration during the selection process.

While specific thematic priorities will be detailed in future calls, Prof. Ajuwon explained that the project’s major research areas include pandemic preparedness and responsiveness, research benefit-sharing, and African-centred approaches to research ethics and governance.

The announcement was enthusiastically received by participants, many of whom described the initiative as a important opportunity to strengthen the capacity of ECR expand access to funding opportunities, and improve female representation in research and global health discourse.

SHARPER is supported by the Africa Pandemic Sciences Collaborative. The Collaborative seeks to mentor, nurture, and equip an emerging generation of young African scientists and researchers to address current and future health challenges, contribute to strengthening the continent’s health ecosystem and pandemic preparedness and response capabilities, and to create pathways to dignified and fulfilling careers in pandemic sciences. The Collaborative is a multi-year partnership between the Science for Africa Foundation (SFA Foundation), the Pandemic Sciences Institute (PSI) at the University of Oxford, and the Mastercard Foundation.

As the training session drew to a close, participants engaged actively in discussions, asking questions, seeking clarification, and sharing reflections on the opportunities presented through the SHARPER Project. The interactive session provided Prof. Ademola Ajuwon with an opportunity to further engage the early-career academics on research development, grant competitiveness, and the broader vision of strengthening African-led research systems.

Going forward, the SHARPER Project remains committed to sustained stakeholder engagement through various communication and knowledge-sharing platforms. These efforts are aimed at ensuring wider visibility for the project, deepening awareness of its objectives, and advancing conversations around research benefit-sharing, pandemic preparedness and responsiveness, and ethical, African-centred approaches to research and global health governance.

Written by Adams Adeshola

Four EPSILON Consortia Launch at UCT to Strengthen Pandemic Preparedness in Africa

On Thursday, 21 May, the Institute of Infectious Disease and Molecular Medicine (IDM) at the University of Cape Town (UCT), South Africa, hosted the soft launch of four consortia funded by the Africa Pandemic Sciences Collaborative through a partnership between the Science for Africa Foundation, the University of Oxford’s Pandemic Sciences Institute, and Mastercard Foundation. Beyond supporting research, this collaboration also invests in strengthening the pandemic sciences ecosystem across the continent.

In total, seven Epidemic and Pandemic Sciences Innovation and Leadership Networks (EPSILONs) have been funded, each led by African scientists and designed to create a network of excellence in epidemic and pandemic sciences. The launch focused on the four consortia in which UCT is either the lead or a partner institution, spanning 11 African countries: Cameroon, Democratic Republic of the Congo (DRC), Ghana, Kenya, Malawi, Nigeria, Senegal, Tanzania, Uganda, Zimbabwe, and South Africa.

Opening remarks were delivered by Professor Wendy Burgers, Deputy Director of IDM, who reflected on the current lack of outbreak preparedness and the unequal global research landscape. Referring to discussions at the World Health Assembly and ongoing outbreaks such as Ebola in the DRC, she highlighted the need for African-led pandemic science and stronger collaboration across the continent.

Christina Pather from the Research Support Enterprise described the launch as “a step towards a stronger, more equitable and more resilient African research ecosystem”, while celebrating UCT’s participation in four of the seven funded projects and the interdisciplinary collaboration this represents.

The first consortium presented was the Consortium for Leadership of Epidemiological-economic Analysis for epidemic Response in Africa (CLEAR-Africa), led by Professor Sheetal Silal. CLEAR-Africa aims to strengthen preparedness for future pandemics by developing models that consider not only disease transmission and health outcomes, but also the social and economic consequences of public health responses. The consortium seeks to address the current modelling skills gap by training African researchers to lead and adapt epidemiological-economic models locally, ensuring that future outbreak responses are informed by both health and economic realities.

Associate Professor Jinal Bhiman then presented Surveillance Platforms and ImmunoLOgy for zoonotic Viruses with pandemic potential in Africa (SPIL-OVA), a consortium working at the human-animal interface to better understand zoonotic threats. SPIL-OVA focuses on identifying viruses with spillover potential circulating in African bat populations, recognised reservoirs of several emerging infections. Through multiple research work packages, the consortium aims to build knowledge about animal viral diversity, strengthen surveillance systems and support diverse leadership and scientific expertise across the continent.

Strengthening Health systems capacity in Africa for Pandemic Equity and Responsiveness (SHARPER) was presented by Professor Leslie London, representing one of the consortium partners. SHARPER seeks to transform how research is conducted and used in Africa by analysing the current policy and research landscape and identifying opportunities for change. The consortium will develop new tools, courses and academic outputs while placing equity, African values and human rights at the centre of pandemic preparedness and response, so as to ensure health research benefits populations and not only participants.

The final consortium presented was Advancing Capacity for Early Phase Trials for Pandemics and Epidemics in Africa (ACCEPT-Africa), presented by Dr Daniel Kiiza and Professor Paolo Denti. ACCEPT-Africa aims to strengthen early-phase clinical trial infrastructure across the continent, enabling trials, protocol development, and pharmacokinetic analysis to be conducted locally. The consortium also focuses on training researchers and laboratory teams so that future clinical research can be led within Africa and better reflect the populations it seeks to serve.

In their closing remarks, Angie Kerubo Mugisha and Dr Linda Murungi from the Africa Pandemic Sciences Collaborative, highlighted the importance of collaboration and thanked the principal investigators for their commitment to strengthening preparedness for future epidemics and pandemics. They reminded the audience that scientific knowledge should not remain within institutions but should reach communities and create impact at individual, institutional and systemic levels.

The launch concluded with a networking reception, bringing together students, researchers, partners, and consortium members. Earlier in the event, Professor Burgers reminded the audience that “Africa doesn’t lack talent; there has been a structural gap that has prevented the continent from working together.” The EPSILON programme seeks to address this gap by strengthening collaboration, leadership and scientific excellence across Africa.

Written by Elisabet Marti Coma-Cros and appeared HERE originally.  

PREPARE: Strengthening Africa’s Foundations for Pandemic Preparedness

Africa’s experience with COVID-19, Ebola, Marburg, Rift Valley Fever, and other infectious disease threats has reinforced a critical lesson: preparedness cannot be outsourced. It must be built, coordinated, and sustained from within. 

Across the continent, new efforts are emerging to strengthen how African institutions collaborate, generate evidence, and respond to future health threats. One such effort is the Prevention and Response to Emerging Viruses with Pandemic Potential in Africa Research Epsilon (PREPARE) Network — a multi-country initiative bringing together leading research institutions to advance pandemic preparedness. 

PREPARE is one of several Epidemic and Pandemic Sciences Innovation and Leadership Networks (EPSILONs) supported under the Africa Pandemic Sciences Collaborative  (the Collaborative). Through these networks, the Collaborative invests in African-led research partnerships that aim to strengthen scientific capacity, enhance collaboration, and support the development of locally driven solutions to emerging health threats. 

An African-Led, Collaborative Approach 

At its core, PREPARE seeks to strengthen One Health approaches to infectious disease surveillance and diagnosis across South Africa, Uganda, Kenya, the Democratic Republic of the Congo (DRC), and Côte d’Ivoire. By integrating human, animal, and environmental health systems, the Network is designed to support earlier detection of epidemic- and pandemic-prone pathogens and improve understanding of how such threats emerge and spread. 

The initiative reflects a growing recognition that effective preparedness depends not only on scientific discovery, but also on strong, coordinated research ecosystems that can respond quickly and collaboratively across borders. 

Building a Network for Surveillance and Research 

Over its implementation period (2025–2030), PREPARE will support the development of interconnected research and surveillance nodes across multiple regions of Africa. Participating institutions will draw on a combination of retrospective biological samples and expanded prospective surveillance across human, animal, and environmental systems. 

The Network is expected to strengthen the use of multi-pathogen diagnostics, genomic sequencing, and other advanced research tools to improve detection and characterization of both known and previously unidentified pathogens. Linking laboratory findings with clinical and epidemiological data will help deepen understanding of how pathogens evolve, transmit, and affect populations. 

While still in its early stages, this integrated approach is intended to contribute to closing critical gaps in early warning systems and strengthening the evidence base for public health decision-making. 

From Detection to Preparedness 

In addition to strengthening surveillance, PREPARE is designed to support research that contributes to future response strategies, including the development of prototype vaccine approaches using emerging technologies. 

By investing in research platforms and scientific collaboration ahead of major outbreaks, such efforts aim to position African institutions to contribute more actively to global pandemic response efforts, while also addressing regional priorities. 

Strengthening Capacity for the Long Term 

A key pillar of the Network is strengthening research capacity across participating institutions. Through linkages with established initiatives such as the Consortium for Advanced Research Training in Africa (CARTA) and other academic partners, PREPARE is expected to support the development of early-career researchers in areas such as genomics, surveillance, and advanced research methodologies. 

Such efforts contribute to building a pipeline of scientists equipped to lead future epidemic preparedness and response efforts across the continent. 

Role of Coordination and Enabling Systems 

Beyond the science itself, PREPARE reflects a broader shift in how large-scale research collaborations are being organized across Africa — with increasing emphasis on partnership, shared infrastructure, and coordinated implementation. 

The PREPARE Network brings together a consortium of African research institutions, with scientific leadership anchored at the Infectious Diseases and Oncology Research Institute  (IDORI) at the University of the Witwatersrand. APHRC plays a central coordination role, supporting program implementation, fund management, and capacity strengthening across the network. 

Partner institutions include  Centre Hospitalier Universitaire de Bouaké (Côte d’Ivoire), Institut National de Recherche Biomédicale (Democratic Republic of the Congo), Kenya Medical Research Institute (Kenya) and the Uganda National Health Research Organisation (Uganda). Together, these institutions form a geographically diverse and technically complementary network. 

As the Network moves into implementation, its success will depend on sustained collaboration, trust among partners, and effective coordination across institutions and countries. 

While still at an early stage, PREPARE offers an important example of how African institutions are working together to build the systems, partnerships, and capabilities needed to strengthen preparedness for future pandemics. In doing so, it reflects a broader shift toward more coordinated, locally driven approaches to addressing global health challenges. 

 Strengthening Africa’s Capacity to Detect and Respond to Emerging Pandemic Threats 

Africa’s experience with COVID-19, Ebola, Marburg, Rift Valley Fever, and other infectious threats has reinforced a powerful lesson: preparedness cannot be outsourced. It must be built, led, and sustained from within. In response, the African Population and Health Research Center (APHRC) is collaborating on an initiative to strengthen Africa’s ability to detect, prevent, and respond to emerging viruses with pandemic potential — the Prevention and Response to Emerging Viruses with Pandemic Potential in Africa Research Epsilon (PREPARE) Network. 

One of several Epidemic and Pandemic Sciences Innovation and Leadership Networks (EPSILONs) supported under the Africa Pandemic Sciences Collaborative (The Collaborative), PREPARE represents a decisive shift from reactive crisis response to proactive, science-driven epidemic preparedness. Through EPSILON networks, The Collaborative invests in African-led research consortia that advance pandemic science, strengthen institutional capacity, and nurture the next generation of African scientists working to predict, prevent, and respond to epidemic threats.  

An African-Led Vision for Pandemic Preparedness 

At the core of PREPARE is a simple but urgent goal: to enhance One Health infectious disease surveillance and diagnosis in South Africa, Uganda, Kenya, the Democratic Republic of the Congo (DRC), and Côte d’Ivoire. This will enable earlier detection of epidemic- and pandemic-prone pathogens and accelerate prototype vaccine development in response to emerging threats. 

This work recognizes that robust One Health research networks, integrating human, animal, and environmental health, are essential for detecting and controlling zoonotic, vector-borne, and respiratory viruses before they spiral into regional or global crises. 

A Continental Network of Surveillance and Scientific Excellence 

Over its implementation period (2025–2030), PREPARE will develop key research and surveillance nodes across South, East, and West Africa. Clinical sites in the five aforementioned countries will leverage: 

  • Retrospectively collected biological samples 
  • Expanded prospective syndromic surveillance in humans, animals, and the environment 
  • Multi-pathogen molecular and serological diagnostics 
  • Rapid diagnostic technologies 
  • Next-generation sequencing platforms 

This integrated approach enables detection of both known and previously unidentified pathogens, closing critical gaps in early warning systems. 

Linking genomic data with clinical and epidemiological insights, the Network will also analyze how viral variants influence severity, transmissibility, and immune evasion. This genotype-to-phenotype characterization is essential for understanding risk and informing targeted interventions. 

From Detection to Vaccine Development 

Unlike traditional surveillance initiatives, PREPARE extends beyond detection. Using innovative research platforms, the Network will develop prototype vaccines using mRNA technologies, Viral vector platforms and Recombinant protein approaches. 

With the investing in prototype vaccine development ahead of major outbreaks, Africa positions itself not only to respond faster but also to contribute to global vaccine innovation. This represents a new frontier: moving from being a site of clinical trials to becoming a hub of vaccine research and development leadership. 

Capacity Strengthening at the Core 

A defining feature of PREPARE is its commitment to sustainable capacity development. The Network will train early-career researchers in One Health surveillance, genomics, vaccine development, and advanced research methodologies. This effort is strengthened through collaboration with the Consortium for Advanced Research Training in Africa (CARTA), a pan-African partnership that has trained hundreds of doctoral fellows and helped strengthen research and PhD training capacity across African universities. By linking PREPARE researchers to this established training ecosystem and other leading academic institutions, the initiative helps nurture a new generation of African scientists equipped to lead epidemic preparedness efforts. 

Coordinated Leadership for Impact 

The PREPARE Network is coordinated by APHRC, which leads overall program implementation, fund management, and capacity strengthening while scientific leadership is provided by the Infectious Diseases and Oncology Research Institute (IDORI) Unit at the University of the Witwatersrand. Partner institutions include: Centre Hospitalier Universitaire de Bouaké (Côte d’Ivoire), Institut National de Recherche Biomédicale (Democratic Republic of the Congo), Kenya Medical Research Institute (Kenya) and the Uganda National Health Research Organisation (Uganda). Together, these institutions form a geographically diverse, technically robust network capable of responding to evolving health threats. 

Positioning Africa for Pandemic Preparedness 

Beyond laboratory and clinical innovation, PREPARE is designed to generate evidence that informs public health decision-making. The Network will produce high-quality data on pathogen emergence, transmission patterns, and potential vaccine candidates, enabling governments and regional bodies to make timely, data-driven decisions. 

Collaboration among leading African research institutions is central to this effort. Working together, partners across the Network are strengthening the continent’s ability to detect threats earlier, respond more rapidly, and advance locally driven scientific solutions. As emerging viruses continue to test global preparedness systems, initiatives such as PREPARE position Africa not only to respond to future outbreaks but also to contribute meaningfully to global epidemic and pandemic preparedness. 

Written by Ann Waithaka and Rita Karoki. This article first appeared on APHRC’s 2026 Newsletter, Issue 1. 

 

up-arrow white-up-arrow